Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Diabetes Care

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.26.3.764PMID 12610035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reference spirometric values using techniques and equipment that meet ATS recommendations.

  2015cited by this paper
• Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.

  2009cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Insulin Aspart

  2001cited by this paper
• Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.

  2001cited by this paper
• Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients

  2001cited by this paper
• Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus

  2001cited by this paper
• Pulmonary Insulin Administration Using the AERx® System: Physiological and Physicochemical Factors Influencing Insulin Effectiveness in Healthy Fasting Subjects

  2000cited by this paper
• Insulin analogues and their potential in the management of diabetes mellitus

  1999cited by this paper
• Deposition of aqueous aerosol of technetium-99m diethylene triamine penta-acetic acid generated and delivered by a novel system (AERx) in healthy subjects

  1999cited by this paper
• Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.

  1999cited by this paper
• Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

  1999cited by this paper
• Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

  1999cited by this paper
• Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients.

  1998cited by this paper
• Inhalation delivery systems with compliance and disease management capabilities.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Design and Testing of Aerosol Delivery Systems for Reproducible Clinical Performance

  1998cited by this paper
• Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment

  1997cited by this paper
• The AERX™ Aerosol Delivery System

  1997cited by this paper
• Time–action Profile of Inhaled Insulin

  1997cited by this paper
• Standardization of Spirometry, 1994 Update. American Thoracic Society.

  1995cited by this paper
• Quantitative evaluation of aerosol deposition pattern in the lung in patients with chronic bronchitis.

  1994cited by this paper
• Comparative Pharmacokinetics and Glucodynamics of Two Human Insulin Mixtures 70/30 and 50/50 insulin mixtures

  1994cited by this paper
• IN VIVO AND IN VITRO B2-ADRENERGIC RECEPTOR RESPONSIVENESS IN YOUNG AND ELDERLY ASTHMATICS

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• In Vivo and In Vitro β2‐Adrenergic Receptor Responsiveness in Young and Elderly Asthmatics

  1992cited by this paper
• Effect of bronchodilation on the deposition and clearance of radioaerosol in bronchial asthma in remission.

  1987cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Albuterol: An Adrenergic Agent for Use in the Treatment of Asthma Pharmacology, Pharmacokinetics and Clinical Use

  1984cited by this paper
• Human insulin.

  1984cited by this paper

• Inhaled Biologics: Overcoming Challenges and Recent Advances.

  2026cites this paper
• The Pharmacokinetics of Inhaled Drugs

  2023cites this paper
• Diabetic Pneumopathy- A Novel Diabetes-associated Complication: Pathophysiology, the Underlying Mechanism and Combination Medication.

  2023cites this paper
• The importance of plasma protein and tissue binding in a drug discovery program to successfully deliver a preclinical candidate.

  2022cites this paper
• Inhaled Medications Employed in Critically Ill Patients

  2021cites this paper
• A COMPREHENSIVE REVIEW ON RECENT ADVANCES IN PULMONARY DRUG DELIVERY SYSTEM

  2021cites this paper
• Consideration of Metal Organic Frameworks for Respiratory Delivery

  2021cites this paper
• A REVIEW: GENERAL CONCEPT ABOUT THE METERED

  2020cites this paper
• Developing inhaled protein therapeutics for lung diseases

  2020cites this paper
• The Discovery of Insulin: An Important Milestone in the History of Medicine

  2018cites this paper
• Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes

  2018cites this paper
• Développement et caractérisation physico-chimique d'une nouvelle forme galénique à base d'Amphotéricine B adaptée à la voie orale et pulmonaire

  2018cites this paper
• Various Emerging Trends in Insulin Drug Delivery Systems

  2015cites this paper
• Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins.

  2015cites this paper
• Carbohydrate Polymers: Colon-Targeted Drug Delivery

  2015cites this paper
• Newer devices and improved formulations of inhaled insulin

  2015cites this paper
• Etat des lieux passé et actuel de l'insuline (thérapies et procédés) et perspectives d'évolution

  2015cites this paper
• Recent Advances in Insulin Therapy for Diabetes

  2014cites this paper
• Feasibility of a 3D human airway epithelial model to study respiratory absorption.

  2014cites this paper
• Colloidal carriers for noninvasive delivery of insulin

  2014cites this paper
• The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update

  2014cites this paper
• Subcutaneous insulin therapy - end of the road after 80 years?

  2014cites this paper
• The impact of pulmonary diseases on the fate of inhaled medicines--a review.

  2014cites this paper
• Proteins, peptides, and controlled-release formulations for inhalation

  2013cites this paper
• Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.

  2013cites this paper
• Simulation of bronchial mucociliary clearance of insoluble particles by computational fluid and particle dynamics methods

  2013cites this paper
• Problems for Biomedical Fluid Mechanics and Transport Phenomena

  2013cites this paper
• Pulmonary drug delivery strategies: A concise, systematic review

  2012cites this paper
• Doctor, stop needling me: an update on alternative routes of insulin administration

  2012cites this paper
• Managing diabetes with inhaled insulin

  2012cites this paper
• Intestinal receptor targeting for peptide delivery: an expert's personal perspective on reasons for failure and new opportunities.

  2011cites this paper
• Inhaled Insulin: Too Soon To Be Forgotten?

  2011influential citation
• Inhalative administration of insulin using a new bubble jet atomization device.

  2011cites this paper
• Novel Hormonal Delivery Method Using the Ink-Jet Technology: Application to Pulmonary Insulin Therapies

  2011cites this paper
• Pulmonary Delivery of Peptides and Proteins

  2011cites this paper
• Aerosol Therapy in the Mechanically Ventilated Patient

  2010cites this paper
• The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.

  2010cites this paper
• Targeting Drugs to the Lungs – The Example of Insulin

  2010cites this paper
• Glycemic Control with Preprandial Versus Basal Insulin in Patients with Type 2 Diabetes Mellitus Poorly Controlled by Oral Antidiabetes Agents

  2010cites this paper
• Inhaled insulin: a model for pulmonary systemic absorption?

  2010influential citation
• The pharmacokinetics of alternative insulin delivery systems.

  2010cites this paper
• Recent trends in protein and peptide drug delivery systems

  2009cites this paper
• Various non-injectable delivery systems for the treatment of diabetes mellitus.

  2009cites this paper
• Inhaled Insulin as alternative delivery system for subjects with diabetes – A literature review

  2009cites this paper
• Safety and Efficacy of AIR Inhaled Insulin Compared with Subcutaneous Insulin in Patients Having Diabetes and Asthma: A 12-Month, Randomized, Noninferiority Trial

  2009cites this paper
• Short-term safety of somatropin inhalation powder in adults with mild to moderate asthma.

  2009cites this paper
• Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes

  2009cites this paper
• Programa de atención integral para una vida sana aplicado en pacientes con DM tipo 2: PRATIVSA-DM

  2009cites this paper
• Nanoparticle formulations in pulmonary drug delivery

  2009cites this paper
• Pure insulin nanoparticle agglomerates for pulmonary delivery.

  2008cites this paper
• New Insulin Analogues and Routes of Delivery

  2008cites this paper
• Inhaled insulin--does it become reality?

  2008cites this paper
• Noninvasive insulin delivery systems

  2008cites this paper
• AIR Inhaled Insulin Versus Subcutaneous Insulin

  2008cites this paper
• Dry powder inhalation systems for pulmonary delivery of therapeutic peptides and proteins

  2008cites this paper
• Current therapies and technological advances in aqueous aerosol drug delivery.

  2008cites this paper
• Can inhaled insulin be used for the treatment of diabetes mellitus?

  2008cites this paper
• L’insuline par voie inhalée : un modèle pour l’absorption systémique pulmonaire ?

  2008cites this paper
• Inhaled human insulin (Exubera®): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus

  2008cites this paper
• Current Therapies and Technological Advances in Aqueous Aerosol Drug Delivery

  2008cites this paper
• [Inhaled insulin: a model for pulmonary systemic absorption?].

  2008cites this paper
• First approved inhaled insulin therapy for diabetes mellitus

  2007cites this paper
• [Inhaled insulin--the breakthrough in the treatment of diabetes?].

  2007cites this paper
• Insulin increases the expression of contractile phenotypic markers in airway smooth muscle.

  2007cites this paper
• Inhaled Insulin in Patients with Asthma and Chronic Obstructive Pulmonary Disease

  2007cites this paper
• [Inhaled insulin and its effects on the lungs].

  2007cites this paper
• Current challenges in non-invasive insulin delivery systems: a comparative review.

  2007cites this paper
• [Aerosol: present and future].

  2007cites this paper
• Pulmonary Function Changes Related to Acute and Chronic Administration of Inhaled Insulin

  2007cites this paper
• The New Insulins

  2007cites this paper
• The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits.

  2007cites this paper
• [Controversies in the association between type 1 diabetes and asthma].

  2007cites this paper
• Inhaled insulin and the lung.

  2007cites this paper
• Inhaled insulin using AERx® insulin Diabetes Management System (AERx® iDMS)

  2007cites this paper
• Inhaled insulin.

  2007cites this paper
• Selection and education of patients for inhaled insulin

  2007cites this paper
• Inhaled insulins

  2007cites this paper
• Delivering Needle-Free Insulin Using AERx® iDMS (Insulin Diabetes Management System) Technology

  2007cites this paper
• Insulin induces airway smooth muscle contraction

  2007cites this paper
• Aérosols : présent et futur

  2007cites this paper
• Exubera: first inhaled insulin for the management of diabetes

  2007cites this paper
• Controvérsias na associação entre diabetes mellitus tipo 1 e asma

  2007cites this paper
• Insulina inhalada y sus efectos sobre el pulmón

  2007cites this paper
• Inhaled insulin and its effects on the lungs

  2007cites this paper
• RESULTS OF INHALED INSULIN THERAPY

  2007cites this paper
• La Suppléance Insulinique : nouvelles insulines, nouveaux procédés d'administration

  2007cites this paper
• RESEARCH PAPER Insulin induces airway smooth muscle contraction

  2007cites this paper
• Perfil clínico de Exubera® en el tratamiento de la diabetes

  2007cites this paper
• Inhaled insulin: where are we and where might we go?

  2007cites this paper
• Inhaled human insulin: a clinical perspective

  2006cites this paper
• Role of inhaled human insulin in the management of Type 1 and 2 diabetes

  2006cites this paper
• Smoking enhances absorption of insulin but reduces glucodynamic effects in individuals using the Lilly‐Dura inhaled insulin system

  2006cites this paper
• Type 1 Diabetes in Children, Adolescents, and Young Adults: How to Become an Expert on Your Own Diabetes

  2006cites this paper
• Inhaled human insulin: an inspiration for patients with diabetes mellitus?

  2006cites this paper
• Inhaled cytokines and cytokine antagonists.

  2006cites this paper
• Insuline en aérosol : quel avenir ?

  2006cites this paper
• Noninjectable methods of insulin administration.

  2006cites this paper
• Inhaled insulin: new technology, new possibilities

  2006cites this paper
• Insulin treatment and type 1 diabetes topics.

  2006cites this paper
• Pulmonary safety of inhaled insulins: a review of the current data

  2006cites this paper